Rein Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| −$6.4 | −$5.8 | −$5.6 | −$6.8 | −$5.5 | −$5.8 | −$8.9 | −$7.1 | |
| −$0.10 | −$0.19 | −$0.21 | −$0.28 | −$0.25 | −$0.27 | −$0.45 | −$0.86 | |
| 67 | 30 | 26 | 24 | 22 | 22 | 20 | 8.3 |
Trend